e-learning
resources
Virtual 2020
Pre-Congress Content
Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis
E. Soares Seixas (Aveiro, Portugal), P. Serra (Aveiro, Portugal), M. Ferreira (Aveiro, Portugal), R. Aguiar (Aveiro, Portugal), P. Ferreira (Aveiro, Portugal)
Source:
Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Session:
Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Session type:
E-poster session
Number:
3538
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Soares Seixas (Aveiro, Portugal), P. Serra (Aveiro, Portugal), M. Ferreira (Aveiro, Portugal), R. Aguiar (Aveiro, Portugal), P. Ferreira (Aveiro, Portugal). Criteria for PF-ILD in a cohort of patients with chronic hypersensitivity pneumonitis. 3538
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018
Fibrosis score predicts mortality in patients with chronic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017
Year: 2017
Mortality risk prediction with ILD-GAP index in a portuguese chronic hypersensitivity pneumonitis cohort
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 4 (3) 00043-2018; 10.1183/23120541.00043-2018
Year: 2018
Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis
Year: 2020
Prognostic characteristics in chronic hypersensitivity pneumonitis.
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Experience with Mepolizumab in a cohort of patients with eosinophilic severe persistent asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Prevalance and outcomes of pulmonary hypertension in chronic hypersensitivity pneumonitis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Occurrence of hypersensitivity to beryllium among patients with diagnosed sarcoidosis. Initial results
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012
Asthma and chronic idiopathic eosinophilic pneumonia (CIEP): a study of 52 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 5s
Year: 2001
Clinical response to mepolizumab in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Prognostic factors in chronic hypersensitivity pneumonitis
Source: Eur Respir Rev, 29 (156) 190167; 10.1183/16000617.0167-2019
Year: 2020
Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Clinical course in hypersensitivity pneumonitis: a review of 38 cases
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Incidence of allergic asthma in patients with sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 232s
Year: 2006
Squeaks in hypersensitivity pneumonitis: prevalence and clinical correlates
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019
Diagnosis, course and management of hypersensitivity pneumonitis
Source: Eur Respir Rev, 31 (163) 210169; 10.1183/16000617.0169-2021
Year: 2022
Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept